NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

• Salisbury Bancorp, Inc. (Nasdaq: SAL), relating to its proposed merger NBT Bancorp, Inc. Under the terms of the merger, SAL shareholders will receive 0.745 shares of NBT per share they own. Click here for more information: https://www.monteverdelaw.com/case/salisbury-bancorp-inc. It is free and there is no cost or obligation to you.
  
  
• Albireo Pharma, Inc. (NASDAQ: ALBO), relating to its proposed sale to Ipsen. Under the terms of the agreement, ALBO shareholders are expected to receive $42.00 in cash per share they own, plus one Contingent Value Right worth a deferred $10.00 per share. Click here for more information: https://www.monteverdelaw.com/case/albireo-pharma-inc. It is free and there is no cost or obligation to you.
  
  
• Duck Creek Technologies, Inc. (NASDAQ: DCT), relating to its proposed sale to Vista Equity Partners. Under the terms of the agreement, DCT shareholders are expected to receive $19.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/duck-creek-technologies-inc. It is free and there is no cost or obligation to you.
  
  
• CinCor Pharma, Inc. (NASDAQ: CINC), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, CINC shareholders are expected to receive $26.00 and one Contingent Value Right worth $10.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/cincor-pharma-inc. It is free and there is no cost or obligation to you.
  

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers in 2013 and 2017-2019 as a Rising Star and in 2022 as a Super Lawyer in Securities Litigation. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, we have recovered or secured over a dozen cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2023 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.